Company Performance Metrics
- Rob Davie: VP and Global General Manager
Karen Cornelissen: Scientific Director
Covance Inc. provides early-and late-stage services to the pharmaceutical, biotechnology, and medical device industries. Its early-stage development services include preclinical and clinical pharmacology services. The company's late-stage services include biomarker services to biotech and pharmaceutical customers, with full management of Phase
II and III clinical studies. It also provides lab testing services to the chemical, agrochemical, and food industries. The company was founded in 1987 and is based in Princeton, N.J.
Covance, the drug development business of Laboratory Corporation of America Holdings (LabCorp), is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real® by providing high-quality nonclinical, clinical and commercialization services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development. Because of their broad experience and specialized expertise, they are in a unique position to supply insights that go above and beyond testing -- They have helped pharmaceutical and biotech companies develop each of the top 50 prescription drugs in the marketplace today.
They also offer laboratory testing services to the chemical, agrochemical and food industries and are a market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase III clinical trial management services.
